WO2006002378A3 - Determination de genes associes au cancer et de cibles therapeutiques utilisant des methodes de cytogenetique moleculaire - Google Patents
Determination de genes associes au cancer et de cibles therapeutiques utilisant des methodes de cytogenetique moleculaire Download PDFInfo
- Publication number
- WO2006002378A3 WO2006002378A3 PCT/US2005/022501 US2005022501W WO2006002378A3 WO 2006002378 A3 WO2006002378 A3 WO 2006002378A3 US 2005022501 W US2005022501 W US 2005022501W WO 2006002378 A3 WO2006002378 A3 WO 2006002378A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- genes
- methods
- regions
- cancerous
- therapeutic targets
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58169904P | 2004-06-23 | 2004-06-23 | |
US60/581,699 | 2004-06-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006002378A2 WO2006002378A2 (fr) | 2006-01-05 |
WO2006002378A3 true WO2006002378A3 (fr) | 2007-07-12 |
Family
ID=35782366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/022501 WO2006002378A2 (fr) | 2004-06-23 | 2005-06-23 | Determination de genes associes au cancer et de cibles therapeutiques utilisant des methodes de cytogenetique moleculaire |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006002378A2 (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100034736A1 (en) * | 2006-09-07 | 2010-02-11 | Consejo Superior De Investigaciones Cientificas | Identification of cancer stem cells using genetic markers |
NZ580195A (en) | 2007-03-05 | 2012-03-30 | Univ Queensland | Targeting crac for breast cancer therapy and/or diagnosis |
WO2009131366A2 (fr) * | 2008-04-21 | 2009-10-29 | 한국생명공학연구원 | Cdca5 en tant que marqueur diagnostique et agent thérapeutique pour le cancer gastrique ou le cancer colorectal |
EP2281201B1 (fr) | 2008-05-14 | 2018-03-28 | ETH Zurich | Procédé pour la découverte de biomarqueur et de cible de médicament pour le diagnostic et le traitement du cancer de la prostate ainsi que les analyses de biomarqueurs déterminés grâce à ce procédé |
EP2313528A4 (fr) | 2008-07-21 | 2012-01-25 | Neodiagnostix Inc | Procédés d'analyse cytologique de cellules cervicales |
RU2519089C2 (ru) * | 2008-08-05 | 2014-06-10 | Торэй Индастриз, Инк. | Способ обнаружения злокачественных опухолей |
AU2009278386B2 (en) | 2008-08-05 | 2015-05-21 | Toray Industries, Inc. | Pharmaceutical composition for treatment and prevention of cancers |
WO2011011527A2 (fr) | 2009-07-21 | 2011-01-27 | Neodiagnostix, Inc. | Procédé et système pour lanalyse automatisée dimages dans les cellules cancéreuses |
CN102821788B (zh) | 2010-02-04 | 2016-11-16 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
JP5923984B2 (ja) | 2010-02-04 | 2016-05-25 | 東レ株式会社 | 癌の治療及び/又は予防のための医薬品 |
KR101758117B1 (ko) | 2010-02-04 | 2017-07-14 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
MX342291B (es) | 2010-02-04 | 2016-09-23 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. |
AU2011211682B2 (en) | 2010-02-04 | 2015-08-13 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
PL2532743T3 (pl) | 2010-02-04 | 2015-09-30 | Toray Industries | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania raka |
CA2844030C (fr) | 2011-08-04 | 2019-09-03 | Toray Industries, Inc. | Composition de medicament pour traitement et/ou prevention du cancer |
KR101979208B1 (ko) | 2011-08-04 | 2019-05-16 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
HUE033628T2 (en) | 2011-08-04 | 2017-12-28 | Toray Industries | Method for detecting pancreatic cancer |
WO2013018891A1 (fr) | 2011-08-04 | 2013-02-07 | 東レ株式会社 | Composition pharmaceutique destinée à traiter ou à prévenir le cancer |
CA2844034C (fr) | 2011-08-04 | 2019-07-16 | Toray Industries, Inc. | Composition de medicament pour traitement et/ou prevention du cancer |
US9409993B2 (en) | 2011-08-04 | 2016-08-09 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
PT2740793T (pt) | 2011-08-04 | 2018-02-23 | Toray Industries | Composição de fármacos para o tratamento e/ou a prevenção de cancro |
IN2014KN01715A (fr) | 2012-02-21 | 2015-10-23 | Toray Industries | |
JP6187258B2 (ja) | 2012-02-21 | 2017-08-30 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
RU2632645C2 (ru) | 2012-02-21 | 2017-10-06 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
KR102005308B1 (ko) | 2012-02-21 | 2019-07-30 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
US9416193B2 (en) | 2012-03-30 | 2016-08-16 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of liver cancer |
DK2832366T3 (en) | 2012-03-30 | 2018-01-22 | Toray Industries | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR PREVENTION OF Gallbladder cancer |
US9753038B2 (en) | 2012-07-19 | 2017-09-05 | Toray Industries, Inc. | Method for detecting cancer via measurement of caprin-1 expression level |
TR201902972T4 (tr) | 2012-07-19 | 2019-03-21 | Toray Industries | Kanseri tespit etmek için yöntem. |
JP6447130B2 (ja) | 2013-08-09 | 2019-01-09 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
-
2005
- 2005-06-23 WO PCT/US2005/022501 patent/WO2006002378A2/fr active Search and Examination
Non-Patent Citations (1)
Title |
---|
TANIGUCHI K. ET AL.: "A Human Canalicular Multispecific Organic Anion Transporter (cMOAT) Gene Is Overexpressed in Cisplatin-Resistant Human Cancer Cell Lines with Decreased Drug Accumulation", CANCER RES., vol. 56, 15 September 1996 (1996-09-15), pages 4121 - 4129, XP003014581 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006002378A2 (fr) | 2006-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006002378A3 (fr) | Determination de genes associes au cancer et de cibles therapeutiques utilisant des methodes de cytogenetique moleculaire | |
WO2006033664A8 (fr) | Determination de genes lies au cancer et cibles therapeutiques utilisant des techniques cytogenetiques moleculaires | |
WO2004111273A3 (fr) | Marqueurs d'expression genique utilises en vue d'une reaction a des medicaments inhibiteurs de egfr | |
WO2002079411A3 (fr) | Etablissement de profils d'expression genique dans un microreseau dans un adenocarcinome a cellules claires, pronostic et identification de cible medicamenteuse | |
WO2004097051A3 (fr) | Techniques et appareils de diagnostic de lam et de mds | |
WO2004091548A3 (fr) | Methodes cytogenetiques moleculaires permettant de determiner des genes associes au cancer et des cibles therapeutiques | |
WO2004086949A3 (fr) | Marqueurs d'adn utilises dans la gestion du cancer | |
WO2008146309A3 (fr) | Variantes génétiques sur les chr 5p12 et 10q26 utilisées comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein | |
EP2295604A3 (fr) | Diagnostic et traitement de cancers à l'aide de microARN présent dans ou au voisinage de caractéristiques chromosomiques associées aux cancers | |
WO2005123942A3 (fr) | Analyse d'acide nucleique methyle | |
WO2008117314A3 (fr) | Variants génétiques du chr2 et chr16 utilisés comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein | |
WO2002024956A8 (fr) | Marqueurs genetiques de tumeurs | |
WO2004097052A3 (fr) | Procedes de pronostic et de traitement de tumeurs solides | |
WO2004000094A3 (fr) | Marqueurs predictifs utilises dans le traitement du cancer | |
WO2004113571A3 (fr) | Genes specifiques de la prostate et leur utilisation comme cibles dans le traitement et le diagnostic du cancer de la prostate | |
WO2006037462A3 (fr) | Marqueurs du cancer | |
WO2006060265A3 (fr) | Methodes et systemes permettant de pronostiquer et de traiter des tumeurs solides | |
WO2005072893A8 (fr) | Compositions metalliques colloidales fonctionnalisees | |
WO2006014999A3 (fr) | Compositions et methodes d'utilisation de modulateurs de nectine 4, de semaphorine 4b, d'igsf9 et de kiaa0152 dans le traitement de maladies | |
WO2004047623A3 (fr) | Procedes pour identifier les risques de cancer du sein et traitements correspondants | |
WO2007002746A3 (fr) | Aberrations moleculaires/genetiques detectees dans les marges chirurgicales d’un cancer du pancreas reseque representant une maladie neoplasique correspondant a l’evolution de la maladie | |
WO2007006862A3 (fr) | Methode et trousse permettant de detecter un risque de coronaropathie | |
WO2003070082A3 (fr) | Utilisation de polymorphismes de nucleotides simples dans le locus comt et dans les loci voisins pour determiner une predisposition a la schizophrenie, au trouble bipolaire, au cancer du sein et au cancer colorectal | |
WO2005047536A3 (fr) | Detection d'amplification et de deletion genomiques dans le cancer | |
WO2003095977A3 (fr) | Methodes de pronostic et de diagnostic du cancer sur la base de cellules endotheliales vasculaires tumorales |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 05790063 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05790063 Country of ref document: EP Kind code of ref document: A2 |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |